A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer
Clinical trial NCT05608876 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05608876
- Sponsor
- QBiotics Group Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-03
- Primary completion
- 2025-07-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.